The House of Representatives passed 250-169 Tuesday (May 22) the Right to Try bill cleared by the Senate last year, sending the bill to the president's desk despite earlier concerns, shared by FDA at the time, that the bill lacked adequate patient safety protections. The president is expected to sign the bill into law. The newly passed bill, which was spearheaded by Sen. Ron Johnson (R-WI) and the libertarian Goldwater Institute, will allow drug companies to provide dying patients with...